Search for: "ACTAVIS"
Results 741 - 760
of 1,006
Sorted by Relevance
|
Sort by Date
13 Jun 2017, 2:33 am
Actavis and Generics [2016] EWCA Civ 1006. [read post]
21 Sep 2021, 12:26 am
The case law on plausibility in the UK is primarily directed to the sufficiency requirement (Warner Lambert v Actavis (IPKat)), but has also been considered in the context of inventive step (Takeda v Roche (IPKat)). [read post]
7 Jul 2015, 1:58 am
No, justsecond medical use ...The sudden return to the headlines of problems relating to second medical use patents, both on last year's AIPPI agenda and in Warner-Lambert's mega-litigation with Actavis over pregabalin [see eg the hugely popular Katposts by Darren, Annsley and even Jeremy here, here, here, here and here] pretty well guaranteed that this issue would feature on this year's programme (incidentally, this is the substantive legal issue that has attracted… [read post]
12 Feb 2018, 2:33 am
EssaysWas the Supreme Court right in Actavis v Eli Lilly to introduce a doctrine of equivalents when determining infringement of patents in the UK? [read post]
18 Aug 2017, 5:56 am
. | Changes to the Singapore copyright system: an update on the recent public consultations | he diplomatic crisis of Qatar and Gulf Cooperation Council's IP | Bundesgerichtshof's landmark ruling to hook extra-territorial patent infringement in Germany | BREAKING: Eli Lilly success as UK Supreme Court finds Actavis products directly and indirectly infringe pemetrexed patent | Monday Miscellany | Sunday Surprises Photo credit: frankieleon [read post]
27 Apr 2015, 10:56 am
It has been all quiet on the pharma patent front since the beginning of March (when the epic series of first instance decisions on Swiss form claims came to and end: see here, here, here and here), and so this moggy was delighted when there fell into his paws the decision of Mr Justice Arnold in Novartis v Focus, Actavis, Teva [2015] EWHC 1068 (Pat).The case concerns a transdermal patch for rivastigmine, which is acetylcholinesterase (AChE) inhibitor used in the treatment of… [read post]
10 Jun 2014, 7:44 pm
In this post, guest contributor Paul England (Taylor Wessing LLP) explains the legal issues and their consequences:UKIPO -- a 'court' for the purposes of the Brussels I Regulation Some courts look like this ...With Actavis v Eli Lilly [noted on the IPKat here] still fresh in our minds, and amendments to the Brussels I Regulation (recast) progressing through the European Parliament in preparation for the Unified Patent Court, jurisdictional matters are a hot topic… [read post]
17 Jan 2022, 1:08 am
Whilst the fact of the cases differ, the PTAB and CAFC reasoning in Teva vs Corcept is markedly different, for example, to the reasoning of the UK High Court in Bayer v Teva [2021] EWHC 2690 (Pat) (IPKat) and Actavis v ICOS (IPKat), in which inventions arising from multi-step drug development programs were found obvious-to-try in view of a known treatment effect for a particular drug, regardless of whether there was an unpredictable technical effect. [read post]
2 Apr 2019, 3:46 pm
Actavis, Bowman v. [read post]
4 May 2019, 6:15 am
| Applying the Actavis questions to numerical limitations: Regen Lab v Estar | Formstein defence in the UK? [read post]
12 Jun 2017, 1:00 am
Reverse payments to delay generic market entry are judged post-Actavis under the “rule of reason”. [read post]
27 Jun 2018, 7:24 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
4 Apr 2016, 11:21 am
| Actavis v Lilly | EU public consultation on neighbouring rights | Life as an IP Lawyer in San Francisco | Copyright in chess games | Trade surplus and IP | Fujifilm Kyowa Biologics v AbbVie Biotechnology. [read post]
8 May 2017, 10:17 am
Here's my checklist|Fujifilm v AbbVie: practice, procedure and policy analysis|Overturning a trade mark opposition decision - Part 2 - SOULUXE - likelihood of confusion|Overturning a trade mark opposition decision - Part 1 - IWATCH, descriptive goods and acquired distinctivenessNever Too Late 143 [week ending on Sunday 9 April] |French court rules that resale right royalty must be only paid by sellers I Tune in LIVE for tomorrow's Eli Lilly v Actavis Supreme Court showdown I Oldie… [read post]
5 Oct 2015, 5:13 am
| IP: When innovation is the answer to a spiritual funkNever Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v Warner-Lambert |… [read post]
28 Mar 2016, 2:59 am
* BREAKING: UK Supreme Court to hear Actavis v Lilly pemetrexed battleThe Supreme Court has just published its list of cases that it will be hearing (or not) on appeal. [read post]
13 May 2014, 9:23 am
"All this is compliant with the GAT and Folien decisions and the Corte di Cassazione ruling, as well the UK decision in Joined cases Actavis Group hf v Eli Lilly & Company (USA) and Medis ehf v Eli Lilly & Company (USA) [here]. [read post]
19 Nov 2019, 12:01 am
Speakers will touch upon a variety of developments in the UK and across Europe, including the doctrine of equivalents following Actavis v Lilly, plausibility and requirements for data in patent applications and recent developments in relation to injunctions, as well as providing an update on case law from the EPO. [read post]
8 Aug 2017, 12:10 pm
. | Changes to the Singapore copyright system: an update on the recent public consultations | he diplomatic crisis of Qatar and Gulf Cooperation Council's IP | Bundesgerichtshof's landmark ruling to hook extra-territorial patent infringement in Germany | BREAKING: Eli Lilly success as UK Supreme Court finds Actavis products directly and indirectly infringe pemetrexed patent | Monday Miscellany | Sunday Surprises Never Too Late 154 [week ending Sunday 2 July] I Book… [read post]
20 Sep 2015, 4:08 pm
******************PREVIOUSLY, ON NEVER TOO LATE Never Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v Warner-Lambert |… [read post]
